References
- Kucera ML, Graham JP. Insulin lispro, a new insulin analog. Pharmacotherapy 1998;18:526–38
- Pampanelli S, Torlone E, LaIli C, et al. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic 13-cell function. Diabetes Care 1999;18:1453–8
- Ebeling P, Jansson PA, Smith A, et al. Strategies toward improved control during insulin lispro therapy in IDDM. Diabetes Care 1997;20:1287–9
- Lalli C, Ciofetta M, Del Sindaco P, et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 1999;22:468–77
- Zinman B, Ross S, Campos RV, et al. The Canadian Lispro Study Group. Effectiveness of human Ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. Diabetes Care 1999; 22:603–8
- Brunelle R, Keohane P, Koivisto V, et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes. Arch Intern Med 1997;157:1249–55
- Zinman B, Tildesley H, Chiasson JL, et al. Insulin lispro in CSII. Results of a double-blind crossover study. Diabetes 1997; 46:440–3
- Kotsanos JG, Vignati L, Huster W, et al. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Diabetes Care 1997;20:948–58
- Glazer N, Zalani S, Anderson J, et al. Safety of insulin lispro: pooled data from clinical trials. Am J Health Syst Pharrn 1999; 56:542–7
- Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro. N Engl J Med 1997;337:1009–10
- Kitzmiller J, Main E, Ward B, et al. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care 1999;22:874–5
- Bhattacharyya A, Vice P. Insulin lispro, pregnancy, and retinopathy. Diabetes Care 1999;22:2101–2
- Buchbinder A, Miodovnik M, McElvy S, et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000; 183:1162–5
- Jovanovic L. Retinopathy risk: what is responsible? hormones, hyperglycemia, or humalog? Diabetes Care 1999;22:846–8
- Cohen M. Use of insulin lispro in pregnancy: a 2-year experi-ence. Diabetes 1999;48 ( Suppll ) : abstract 468
- Rosen SG, Engel SS. Use of insulin lispro in pregnant women with diabetes mellitus. Diabetes 1998;48(Suppll ):abstr 1670
- Bhattacharyya A, Brown S, Hughes S, et al. Insulin lispro and regular insulin in pregnancy. Q J Med 200194:255–60
- Menon RK, Cohen RM, Sperling MA, et al. Transplacental passage of insulin in pregnant women with insulin dependent diabetes mellitus. Its role in fetal macrosomia. N Engl J Med 1990;323 :309–15
- Rosenn B, Miodovnik M, Combs CA, et al. Human versus animal insulin in the management of insulin-dependent diabetes: lack of effect on fetal growth. Obstet Gynecol 199178:590–3
- Rosenn B, Kossenjans W, Eis A, et al. Does lispro insulin cross the human placenta? Am J Obstet Gynecol 2001184:S69
- Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immuno-logic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422–7
- Ilic S, Jovanovic L, Pettitt D, et al. Insulin lispro: safe and effec-tive treatment option for gestational diabetes. Diabetologia 1998;48(Suppll ):abstr 184
- Garg SK, Pennington M, Gottlieb P, et al. Comparison of maternal and fetal outcomes between human regular and Humalog insulin treated pregnancies in type 1 diabetics. Diabetes 1999:48(Suppll ):abstr 0261
- Anderson JH, Bastyr EJ, Wishner KL. Possible adverse fetal effect of insulin lispro. N Engl.] Med 1997;337:1010
- Idama TO, Lindow SW, French M, et al. Preliminary experi-ence with the use of insulin lispro in pregnant diabetic women. J Obstet Gynecol 2001;21:350–1
- Alawi H. Use of insulin lispro in pregnant women. Diabetes 2001;50\(Supp12):abstr 381
- Kitzmiller JL. Response to Bhattacharyya and Vice. Diabetes Care 1999;22:2102–3
- Buchbinder A, M iodovnik M, Khoury J. Response to the letter to the editor. Am J Obstet Gynecol 2001;185:774–5